AR
GH icon

Advisory Research’s Guardant Health GH Stock Holding History

Advisory Research’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,273
Closed -$531K – 380
2021
Q2 		$531K Sell
4,273
-512
-11% -$68.9K 0.04% 260
2021
Q1 		$730K Sell
4,785
-4,610
-49% -$697K 0.05% 235
2020
Q4 		$1.21M Sell
9,395
-1,642
-15% -$189K 0.09% 174
2020
Q3 		$1.23M Buy
11,037
+2,614
+31% +$239K 0.12% 155
2020
Q2 		$683K Buy
8,423
+2,038
+32% +$164K 0.06% 213
2020
Q1 		$444K Sell
6,385
-8,882
-58% -$682K 0.03% 205
2019
Q4 		$1.19M Sell
15,267
-6,149
-29% -$443K 0.05% 167
2019
Q3 		$1.37M Sell
21,416
-7,307
-25% -$644K 0.07% 152
2019
Q2 		$2.48M Buy
28,723
+7,648
+36% +$584K 0.05% 171
2019
Q1 		$1.62M Buy
21,075
+4,715
+29% +$261K 0.03% 202
2018
Q4 		$615K Buy
+16,360
New +$603K 0.01% 277

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Advisory Research's GH Position: Q3 2021 in Review

Advisory Research sold out of Guardant Health (GH) in Q3 2021, closing a stake of 4,273 shares — an estimated $531K sold.

Advisory Research first reported a position in GH in Q4 2018 and held it in 11 quarters. The position peaked at $2.48M in Q2 2019. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

  • Advisory Research reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
  • Advisory Research sold 4,273 Guardant Health shares in Q3 2021, an estimated $531K.
  • Advisory Research first reported a position in Guardant Health in Q4 2018 and held it in 11 quarters.
  • Advisory Research's Guardant Health position peaked at $2.48M in Q2 2019.
  • 374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Advisory Research's 13F filing for Q3 2021, filed 12 Nov 2021.